Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies

Blood

Volumn 87, Issue 4, 1996, Pages 1502-1511

  Le Couedic, Jean Pierre ^b   Mitjavila, Maria Theresa ^b   Villeval, Jean Luc ^b   Feger, Frédéric ^b   Gobert, Stéphanie ^b   Mayeux, Patrick ^b   Casadevall, Nicole ^b   Vainchenker, William ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; PHOSPHOPROTEIN; SERINE; TYROSINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BURST FORMING UNIT E; CELL DIFFERENTIATION; COLONY FORMING UNIT E; CONTROLLED STUDY; ERYTHROLEUKEMIA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOUSE; NONHUMAN; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0030021792     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1502.bloodjournal8741502     Document Type: Article

References (54)

1. Ben-David Y, Bernstein A: Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66:831, 1991
2. Correa PN, Eskinazi D, Axelrad AA: Circulating erythroid progenitors in polycythemia vera are hypersensitive to insuline-like growth factor-1 in vitro: Studies in an improved serum-free medium. Blood 83:99, 1994
3. Prchal JF, Axelrad AA: Bone marrow responses in polycythemia vera. N Engl J Med 290:1382, 1974
4. Prchal JF, Adamson JW, Murphy S, Steinmann L, Fialkow PJ: Polythemia vera. The in vitro response of normal and abnormal cell lines to erythropoietin. J Clin Invest 61:1044, 1978
5. Eaves CJ, Eaves AC: Erythropoietin (EP) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood 52:1196, 1978
6. Lacombe C, Casadevall N, Varet B: Polycythemia vera: In vitro studies of circulating erythroid progenitors. Br J Haematol 44:189, 1980
7. Villeval JL, Cramer P, Lemoine F, Henri A, Bettaieb A, Bernaudin F, Beuzard Y, Berger R, Flandrin G, Breton-Gorius J, Vainchenker W: Phenotype of early erythroblastic leukemias. Blood 68:1167, 1986
8. Mitjavila MT, Villeval JL, Cramer P, Henri A, Gasson J, Krystal G, Tulliez M, Berger R, Breton-Gorius J, Vainchenker W: Effect of granulocyte-macrophage colony-stimulating factor and erythropoietin on leukemic erythroid colony formation in human early erythroblastic leukemias. Blood 70:965, 1987
9. Mitjavila MT, Le Couedic JP, Casadevall N, Navarro S, Villeval JL, Dubart A, Vainchenker W: Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro. J Clin Invest 77:461, 1991
10. Li J-P, D'Andrea AD, Lodish HF, Baltimore D: Activation of cell growth by binding of friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343:762, 1990
11. Ruscetti SK, Janesch NJ, Chakraborti A, Sawyer ST, Hankins WT: Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line. J Virol 64:1057, 1990
12. Casadevall N, Lacombe C, Muller O, Gisselbrecht S, Mayeux P: Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemic cells. J Biol Chem 266:16015, 1991
13. Zon LI, Moreau J-F, Koo J-W, Mathey-Prevot B, D'Andrea AD: The erythropoietin transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 gtycoprotein. Mol Cell Biol 12:2949, 1992
14. Watowich SS, Yoshimura A, Longmore GD, Hilton DJ, Yoshimura Y, Lodish HF: Homodimerization and constutive activation of the erythropoietin receptor. Proc Natl Acad Sci USA 89:2140, 1992
15. Yoshimura A, Longmore G, Lodish HF: Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 348: 647, 1990
16. Longmore GD, Lodish HF: An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: A cytokine receptor superfamily oncogene. Cell 67:1089, 1991
17. Youssoufian H, Longmore G, Neumann D, Yoshimura A, Lodish HF: Structure, function, and activation of the erythropoietin receptor. Blood 81:2223, 1993
18. De la Chapelle A, Sistonen P, Lehväslaiho H, Ikkala E, Juvonen E: Familial erythrocytosis genetically linked to erythropoietin receptor gene. Lancet 341:82, 1993
19. Juvonen E, Ikkala E, Fyhrquist F, Ruutu T: Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. Blood 78:3066, 1991
20. De La Chapelle A, Traskelin A, Juvonen E: Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci USA 90:1980, 1993
21. Sokol L, Luhovy M, Guan Y, Prchal JF, Semenza GL, Prchal JT: Primary familial polycythemia: A frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood 86:15, 1995
22. D'Andrea AD, Yoshimura A, Youssoufian H, Zon L, Koo J, Lodish HF: The cytoplasmic region of the erythropoietin receptor contains non overlapping positive and negative growth-regulatory domains. Mol Cell Biol 11:1980, 1991
23. Klingmüller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signals. Cell 80:729, 1995
24. Yi T, Zhang J, Miura O, Ihle JN: Hematopoietic cell phosphate associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: Identification of potential binding sites. Blood 85:87, 1995
25. Sokol L, Prchal JF, D'Andrea A, Rado TA, Prchal JT: Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia. Exp Hematol 22:447, 1994
26. Chretien S, Moreau-Gachelin F, Apiou F, Courtois G, Mayeux P, Dutrillaux B, Cartron JP, Gisselbrecht S, Lacombe C. Putative oncogenic role of the erythropoietin receptor in murine and human erythroleukemia cells. Blood 83:1813, 1994
27. Ward JC, Harris KW, Penny LA, Forget BG, Kitamura T, Winkelmann JC: A structurally abnormal erythropoietin receptor gene in a human erythroleukemia cell line. Exp Hematol 20:371. 1992
28. Winkelmann JC, Ward J, Mayeux P, Lacombe C, Schimmenti L, Jenkins RB: A translocated erythropoietin receptor gene in a human erythroleukemia cell line (TF-1) expresses an abnormal transcript and a truncated protein. Blood 85:179, 1995
29. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnovsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H: SH2 domains recognize specific phosphopeptide sequences. Cell 72:767, 1993
30. Berlin NI: Diagnosis and classification of the polycythemias Semin Hematol 12:339, 1975
31. Sambrook J, Fritsch EF, Mamatis T: Analysis and cloning of eukaryotic genomic DNA, in Ford N, Nolan C, Fergusson M (eds): Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989, p 16
32. Maouche L, Tournamille C, Hattab C, Boffa G, Cartron J-P, Chretien S: Cloning of the gene encoding the human erythropoietin receptor. Blood 78:2557, 1991
33. Noguchi CT, Bae KS, Chin K, Wada Y, Schechter AN, Hankins WD: Cloning of the human erythropoietin receptor gene. Blood 78:2548, 1991
34. Winkelmann JC, Penny LA, Deaven LL, Forget BG, Jenkins RB: The gene for the human erythropoietin receptor: Analysis of the coding sequence and assignment to chromosome 19p. Blood 76:24, 1990
35. Saiki R: Amplification of genomic DNA, in Innes M, Gelfand D, Sninsky J, White T (eds): PCR Protocols: A Guide to Methods and Application. San Diego, CA, Academic, 1990, p 13
36. Mitjavila MT, Vinci G, Villeval JL, Kieffer N, Henri A, Testa U, Breton-Gorius J, Vainchenker W: Human platelet alpha granules contain a non specific inhibitor of megakaryocyte colony formation: Its relationship to type âtransforming growth factor (TGF-β). J Cell Physiol 134:93, 1988
37. Jones SS, D'Andrea AD, Haines LL, Wong GG. Human erythropoietin receptor: Cloning, expression, and biologic characterization. Blood 76:31, 1990
38. Adra CN, Boer PH, McBurney MW: Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene 60:65, 1987
39. Fraker PJ, Speck JCJ: Protein and cell membrane iodinations with a sparingly soluble chloramide, 1, 3, 4, 6-tetrachloro-3a, 6a-diphenylglycoluril. Biochem Biophys Res Commun 80:849, 1978
40. Gough NM, Metcalf D, Gough J, Grail D, Dunn AR: Structure and expression of the mRNA for murine granulocyte-macrophage colony stimulating factor. EMBO J 4:645, 1985
41. Dusanter-Fourt I, Casadevall N, Lacombe C, Muller O, Billat C, Fischer S, Mayeux P: Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. J Biol Chem 267:10670, 1992
42. Damen JE, Liu L, Cutler RL, Krystal G: Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood 82:2296, 1993
43. Gobert S, Porteu F, Pallu S, Muller O, Sabbah M, Dusanter-Fourt I, Courtois G, Lacombe C, Gisselbrecht S, Mayeux P: Tyrosine phosphorylation of the erythropoietin receptor: Role for differentiation and mitogenic signal transduction. Blood 86:598, 1995
44. Means RT, Krantz SB, Sawyer S, Gilbert H: Erythropoietin receptors in polycythemia vera J Clin Invest 84:1340, 1989
45. Emanuel PD, Eaves CJ, Broudy VC, Papayannopoulou T, Moore MR, D'Andrea AD, Prchal JF, Eaves AC, Prchal JT: Familial and congenital polycythemia in three unrelated families. Blood 79:3019, 1992
46. Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L: Polycythemia vera: Stem cell and probable clonal origin of the disease. N Engl J Med 295:913, 1976
47. Hess G, Rose P, Gamm H, Papadileris S, Huber C, Seliger B: Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera. Br J Haematol 88:794, 1994
48. Tauchi T, Boswell HS, Leibowtz D, Broxmeyer HE: Coupling between p210bcr-abl and She and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to Ras activation pathway. J Exp Med 179:1994
49. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307, 1994
50. Krosi J, Damen JF, Krystal G, Humphries RK: Erythropoietin and interleukin-3 induce distinct events in erythropoietin receptor-expressing BA/F3 cells. Blood 85:50, 1995
51. Liboi E, Carroll M, D'Andrea AD, Mathey-Prevot B: Erythropoietin receptor signals both proliferation and erythroid-specific differentiation. Proc Natl Acad Sci USA 90:11351, 1993
52. Lacombe C, Chretien S, Lemarchandel V, Mayeux P, Romeo P-H, Gisselbrecht S, Cartron J-P: Spleen focus-forming virus long terminal repeat insertional activation of the murine erythropoietin receptor gene in the T3CL-2 friend leukemic cell line. J Biol Chem 266:6952, 1991
53. Hilton DJ, Watowich SS, Murray PJ, Lodish HF: Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor. Proc Natl Acad Sci USA 92:190, 1995
54. Tauchi T, Feng G-S, Shen R, Hoatlin M, Bagby GCJ, Kabat D, Lu L, Broxmeyer HE: Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J Biol Chem 270:5631, 1995